Abstract
Adenoviruses have become a popular vehicle for gene transfer into animal and human cells. However, wide prevalence of preexisting immunity to human adenovirus (HAdV) and the promiscuous nature of the virus have made the use of nonhuman adenoviruses an attractive alternative. Moreover, readministration of viral vectors is often required to maintain therapeutic levels of transgene expression, resulting in vector-specific immune responses. Although a number of features of bovine adenovirus (BAdV)-3 make it attractive for use as a vector in human vaccination, BAdV-3 transduces nonbovine cells, including human cells, poorly. However, genetic modification of capsid proteins (e.g., fiber, pIX) has helped in increasing the utility of BAdV-3 as a vector for transducing nonbovine cells. Here, we will describe the methods used to construct recombinant BAdV-3 expressing chimeric fiber or chimeric pIX proteins.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mattson, D. E., Norman, B. B., and Dunbar, J. R. (1988) Bovine adenovirus type-3 infection in feedlot calves. Am. J. Vet. Res. 49, 67–69.
Ziiyama, Y., Igarashi, K., Tsukamoto, K., Kurokawa, T., and Sugino, Y. (1975) Biochemical studies on bovine adenovirus type 3. I. Purification and properties. J. Virol. 16, 621–633.
Lee, J. B., Baxi, M. K., Idamakanti, N., et al. (1998) Genetic organization and DNA sequence of early region 4 of bovine adenovirus type 3. Virus Genes 17, 99–100.
Baxi, M., Reddy, P. S., Zakhartchouk, et al. (1998) Characterization of bovine adenovirus type 3 early region 2B. Virus Genes 16, 313–316.
Reddy, P. S., Idamakanti, N., Zakhartchouk, A. N., et al. (1998) Nucleotide sequence, genome organization, and transcription map of bovine adenovirus type 3. J. Virol. 72, 1394–1402.
Baxi, M. K., Babiuk, L. A., Mehtali, M., and Tikoo, S. K. (1999) Transcription map and expression of bovine herpesvirus-1 glycoprotein D in early region 4 of bovine adenovirus-3. Virology 261, 143–152.
Idamakanti, N., Reddy, P. S., Babiuk, L. A., and Tikoo, S. K. (1999) Transcription mapping and characterization of 284R and 121R proteins produced from early region 3 of bovine adenovirus type 3. Virology 256, 351–359.
Reddy, P. S., Chen, Y., Idamakanti, N., Pyne, C., Babiuk, L. A., and Tikoo, S. K. (1999) Characterization of early region 1 and pIX of bovine adenovirus-3. Virology 253, 299–308.
Chartier, C., Degryse, E., Ganter, M., Dieterle, A., and Mehtali, M. (1996) Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 70, 4805–4810.
Rasmussen, U. B., Benchaibi, M., Meyer, V., Schlesinger, Y., and Schughart, K. (1999) Novel human gene therapy vectors: Evaluation of wild-type and recombinant animal adenoviruses in human derived cells. Hum. Gene Ther. 10, 2587–2599.
Reddy, P. S., Idamakanti, N., Chen, Y., et al. (1999) Replication-defective bovine adenovirus type 3 as an expression vector. J. Virol. 73, 9137–9144.
Zhou, Y., Reddy, P. S., Babiuk, L. A., and Tikoo, S. K. (2001) Bovine adenovirus type 3 E1B (small) protein is essential for growth in bovine fibroblast cells. Virology 288, 264–274.
Zakhartchouk, A. N., Reddy, P. S., Baxi, M., et al. (1998) Construction and characterization of E3-deleted bovine adenovirus type 3 expressing full-length and truncated form of bovine herpesvirus type 1 glycoprotein gD. Virology 250, 220–229.
Baxi, M. K., Robertson, J., Babiuk, L. A., and Tikoo, S. K. (2001) Mutational analysis of early region 4 of bovine adenovirus type 3. Virology 290, 153–163.
Baxi, M. K., Deregt, D., Robertson, J., Babiuk, L. A., Schlapp, T., and Tikoo, S.K. (2000) Recombinant bovine adenovirus type 3 expressing bovine viral diarrhea E2 induces an immune response in cotton rats. Virology 278, 234–243.
Reddy, P. S., Idamakanti, N., Zakhartchouk, L. N., Babiuk, L. A., Mehtali, M., and Tikoo, S. A. (2000) Optimization of bovine coronavirus hemagglutinin-estrase glycoprotein expression in E3 deleted bovine adenovirus-3. Virus Res. 70, 65–73.
Tikoo, S. K. (2001) Animal adenovirus as a live vaccine vector. Recent Res. Dev. Virol. 3, 495–503.
Xing, L., Zhang, L., Van Kessel, J., and Tikoo, S. K. (2003) Identification of cisacting sequences required for selective packaging of bovine adenovirus type 3 DNA. J. Gen. Virol. 84, 2947–2956.
Zakhartchouk, A. N., Pyne, C., Mutwiri, G. K., et al. (1999) Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1. J. Gen. Virol. 80, 1263–1269.
Zakhartchouk, A. N., Connors, W., van Kessel, A., and Tikoo, S. K. (2004) Bovine adenovirus type 3 containing heterologous protein in the C-terminus of minor capsid protein pIX. Virology 320, 291–300.
Moffatt, S., Hays, J., HogenEsch, H., and Mittal, S. K. (2000) Circumvention of vector-specific neutralizing antibody response by alternating use of human and non-human adenoviruses: implications in gene therapy. Virology 272, 159–167.
Wu, Q. and Tikoo, S. K. (2004) Altered tropism of recombinant bovine adenovirus type 3. Virus Res. 99, 9–15.
Wu, Q., Chen, Y., Kulshreshtha, V., and Tikoo, S. K. (2004) Characterization and nuclear localization of the fiber protein encoded by the late region 7 of bovine adenovirus type 3. Arch. Virol. 149, 1783–1799.
Chroboczek, J., Bieber, F., and Jacrot, B. (1992) The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus 2. Virology 186, 280–285.
van Olphen, A. L. and Mittal, S. K. (2002) Development and characterization of bovine x human hybrid cell lines that efficiently support the replication of both wild-type bovine and human adenoviruses and those with E1 deleted. J. Virol. 76, 5882–5892.
Hirt, B. (1967) Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26, 365–369.
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
Gallagher, S. R., Winston, S. E., Fuller, S. A., and Hurrell, G. R. J. (2005) Immunoblotting and immunodetection, in Current Protocols in Molecular Biology (Ausubel, F. M., Brent, R., Kingston, R. E., et al., eds.), Wiley & Sons, New York, pp. 10–18.
Bonifacino, J. S., Dell’Angelica, E. C., and Springer, T. A. (2005) Immunoprecipitation, in Current Protocols in Molecular Biology (Ausubel, F. M., Brent, R., Kingston, R. E., et al., eds.), Wiley & Sons, New York, pp. 10–16.
Zhou, Y., Pyne, C., and Tikoo, S. K. (2001) Determination of bovine adenovirus-3 titer based on immunohistochemical detection of DNA binding protein in infected cells. J. Virol. Meth. 94, 148–154.
Douglas, J. T., Rogers, B. E., Rosenfeld, M. E., Michael, S. I., Feng, M., and Curiel, D. T. (1996) Targeted gene delivery by tropism-modified adenovirus vectors. Nat. Biotechnol. 14, 1574–1578.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc.
About this protocol
Cite this protocol
Zakhartchouk, A.N., Wu, Q., Tikoo, S.K. (2007). Construction of Capsid-Modified Recombinant Bovine Adenovirus Type 3. In: Wold, W.S.M., Tollefson, A.E. (eds) Adenovirus Methods and Protocols. Methods in Molecular Medicine, vol 130. Humana Press. https://doi.org/10.1385/1-59745-166-5:91
Download citation
DOI: https://doi.org/10.1385/1-59745-166-5:91
Publisher Name: Humana Press
Print ISBN: 978-1-58829-598-9
Online ISBN: 978-1-59745-166-6
eBook Packages: Springer Protocols